Severity of Acute COVID-19 Tied to Frequency of Long COVID Diagnosis
TUESDAY, Dec. 13, 2022 (HealthDay News) -- The frequency of occurrence of long COVID substantially differs based on severity of the acute infection, according to a study published online Dec. 7 in the Journal of Internal Medicine.
Pontus Hedberg, M.D., from the Karolinska Institutet in Stockholm, and colleagues used data from 204,805 adults with a verified severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (March 2020 through July 2021). Frequency of diagnosis of a post-COVID-19 condition (PCC) 90 to 360 days after a positive test was assessed.
The researchers found that the proportion receiving a PCC diagnosis was 1 percent among individuals not hospitalized for COVID-19, 6 percent among hospitalized individuals, and 32 percent among intensive care unit (ICU)-treated individuals. New-onset symptom diagnosis codes most commonly included fatigue (29 percent) among nonhospitalized individuals and dyspnea among both hospitalized (25 percent) and ICU-treated (41 percent) individuals. Among both nonhospitalized and hospitalized individuals, female sex was associated with a PCC diagnosis, as were previous mental health disorders and asthma. Among individuals with a PCC diagnosis, up to one year after acute infection, the monthly proportion of individuals with outpatient care was substantially elevated versus before infection and was largely attributed to PCC-related care.
"The elevated outpatient primary and specialist care use indicates poor recovery for individuals suffering from post-COVID-19 condition, highlighting the urgent need to better understand this condition and its potential resolution over time," Hedberg said in a statement.
Related Posts
More Hospitalizations, ER Visits in Nursing Homes With Higher Levels of Black Residents
MONDAY, June 19, 2023 (HealthDay News) -- A new study finds that nursing homes...
Unos anestesiólogos con demasiado trabajo pueden poner a los pacientes quirúrgicos en riesgo
JUEVES, 21 de julio de 2022 (HealthDay News) -- Unos anestesiólogos agobiados y...
House Passes Bill To Limit Insulin Costs to $35 a Month
FRIDAY, April 1, 2022 (HealthDay News) -- Americans who use insulin to control...
Johnson & Johnson Agrees to $8.9 Billion Settlement in Talcum Powder Lawsuit
WEDNESDAY, April 5, 2023 (HealthDay News) -- Tens of thousands of people suing...